Thrombotic complications following the administration of high-dose prothrombin complex concentrate for acute warfarin reversal
- 1 August 2016
- journal article
- case report
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 34 (8) , 1736.e1-1736.e3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled StudiesAnnals of Emergency Medicine, 2016
- Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trialThe Lancet, 2015
- Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major BleedingCirculation, 2013
- An update of consensus guidelines for warfarin reversalMedical Journal of Australia, 2013
- An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergenciesHaematologica, 2012
- Evidence-Based Management of Anticoagulant TherapyChest, 2012
- Guidelines on oral anticoagulation with warfarin – fourth editionBritish Journal of Haematology, 2011
- Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapyTransfusion Medicine, 2010
- Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapyHematology, 2007
- Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: An open, prospective randomized controlled trialThrombosis Research, 2006